1 active not recruiting, 1 completed, 1 unknown. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow AIN3: new trials by email Literature Review of AIN3 trials Research Report on AIN3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine (Hansenula Polymorpha), Placebo - Genital Wart, Penile Cancer | Phase 3 | Active not recruiting | Shanghai Bovax Biotechnology Co., Ltd. | 9000 | 2024-07-11 | 2024-12-12 |
| Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old Placebo among 18-45 yrs, Placebo among 9-17 yrs - Penile Cancer, Anal Cancer | Phase 1 | Completed | Shanghai Bovax Biotechnology Co., Ltd. | 90 | 2022-09-23 | 2024-04-17 |
| ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS. Detection of anal HSIL in a routine colonoscopy. - AIN3, AIN2 | Unknown | University Fernando Pessoa | 100 | 2021-08-26 | 2022-12-12 |
Anus Neoplasms (2) · Condylomata Acuminata (2) · Penile Neoplasms (2) · Squamous Intraepithelial Lesions (1)
Pathological Conditions, Signs and Symptoms (3) · Anus Diseases (2) · Colorectal Neoplasms (2) · Communicable Diseases (2) · DNA Virus Infections (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Disease Attributes (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Infections (2) · Intestinal Diseases (2)
Shanghai Bovax Biotechnology Co., Ltd. (2) · University Fernando Pessoa (1)
China (2) · Portugal (1)
Lidong Gao, Master (1) · Long Sui, Doctor (1) · Ting Huang (1)